SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Markets pare gains in late trade

10 Jun 2026 Evaluate

Indian equity markets pared gains in late afternoon session amid weak global market cues. Asian equity markets were trading mostly in red as traders awaited release of U.S. CPI data, while European equity markets were trading lower as tensions between Iran and US escalated after US carried out ‘self-defence strikes’ against Iran in response to the downing of a US helicopter by Iranian forces. However, Indian markets continued to trade above the neutral lines as investors were optimistic after SBI research in its latest Ecowrap report said that the Reserve Bank of India’s (RBI) recent measures to attract foreign capital are expected to bring in $55-65 billion of inflows in the current fiscal (FY27), helping stabilise the rupee and turning the country's balance of payments (BoP) into a surplus. 

The BSE Sensex is currently trading at 74279.77, up by 361.01 points or 0.49% after trading in a range of 73897.83 and 74613.01. There were 16 stocks advancing against 14 stocks declining on the index.

The only gaining sectoral indices on the BSE were FMCG up by 1.09% and Bankex up by 0.19%, while Telecom down by 1.68%, Metal down by 1.50%, Oil & Gas down by 1.48%, Energy down by 1.39% and Power down by 0.90% were the top losing indices on BSE.

The top gainers on the Sensex were Axis Bank up by 2.48%, Kotak Mahindra Bank up by 1.86%, Hindustan Unilever up by 1.84%, ICICI Bank up by 1.74% and HDFC Bank up by 1.53%. On the flip side, Infosys down by 2.77%, Tata Steel down by 1.82%, Eternal down by 1.51%, Titan Company down by 1.40% and Bajaj Finserv down by 1.04% were the top losers.

Meanwhile, highlighting the pharmaceutical sector’s growing global influence, Union Minister of Commerce and Industry Piyush Goyal has said that India is well positioned to serve the world as an innovator, manufacturer, reliable supplier of affordable medicines, partner in advanced healthcare technologies and destination for contract manufacturing.

Minister also noted that India’s pharmaceutical industry has recorded significant export growth, with shipments increasing from roughly $14 billion in FY15 to about $31 billion in FY26. He pointed out that Indian medicines have established a global reach spanning over 200 countries. He added that while India continues to maintain its leadership in generic medicines, the sector is increasingly moving towards innovation-driven growth. According to him, India’s pharmaceutical sector reflects the country’s commitment to ensuring wider access to quality and affordable healthcare across the world. 

Goyal said trust, innovation and partnership form the foundation of India’s pharmaceutical strength. He noted that Indian medicines are widely accepted across global markets owing to the industry’s established quality standards and manufacturing capabilities. He also highlighted the sector’s growing focus on research, innovation, advanced technologies and higher-value products, and invited global companies to invest, manufacture and collaborate in India.

The CNX Nifty is currently trading at 23309.90, up by 67.80 points or 0.29% after trading in a range of 23217.30 and 23425.35. There were 25 stocks advancing against 25 stocks declining on the index.

The top gainers on Nifty were Axis Bank up by 2.48%, Nestle up by 1.89%, Hindustan Unilever up by 1.87%, Kotak Mahindra Bank up by 1.85% and ICICI Bank up by 1.79%. On the flip side, Hindalco down by 3.31%, Coal India down by 3.04%, Infosys down by 2.77%, ONGC down by 2.61% and Tata Steel down by 1.89% were the top losers.

Asian equity markets were trading mostly in red; Nikkei 225 slipped 1226.63 points or 1.91% to 64,190.00, Taiwan Weighted lost 1478.9 points or 3.42% to 43,225.54, Hang Seng declined 184.9 points or 0.76% to 24,381.00, KOSPI dropped 366.11 points or 4.74% to 7,730.82, Straits Times fell 62.57 points or 1.26% to 4,960.68 and Shanghai Composite weakened 16.8 points or 0.42% to 3,993.23, while Jakarta Composite gained 192.52 points or 3.24% to 5,939.17.

European equity markets were trading lower; UK’s FTSE 100 decreased 30.29 points or 0.3% to 10,197.04, France’s CAC fell 10.03 points or 0.12% to 8,193.40 and Germany’s DAX lost 187.16 points or 0.77% to 24,245.90.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×